Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

CPH/NOVO.B stock hub

CPH/NOVO.B has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CPH/NOVO.Bis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3T

Copenhagen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CPH/NOVO.B

In the news

Latest news · CPH/NOVO.B

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.1

P25 14.6P50 19.5P75 24.2

Trailing P/E10.6

P25 11.8P50 20.8P75 32.9

ROE71.4

P25 -4.6P50 11.3P75 24.2

ROIC40.4

P25 -8.1P50 8.5P75 13.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CPH/NOVO.B market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

250

Groups with data

Currency

DKK

Showing 250 of 250 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	DK
Employees	69,505
Employees Change	-7,844%
Employees Change Percent	-10.14
Enterprise value	DKK 1.4T
Exchange	Copenhagen Stock Exchange
Financial currency	DKK
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	DK0062498333
Last refreshed	2026-05-10
Market cap	DKK 1.3T
Price	DKK 290
Price currency	DKK
Rev Per Employee	4,827,687.78x
Sector	Healthcare
Sic	2834
Symbol	cph/NOVO.B
Website	https://www.novonordisk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.48%
EV Earnings	11.57x
EV/EBIT	8.74x
EV/EBITDA	8.04x
EV/FCF	23.36x
EV/Sales	4.31x
FCF yield	4.7%
Forward P/E	14.11x
P/B ratio	6.34x
P/E ratio	10.59x
P/S ratio	3.93x
PE Ratio10 Y	25.85x
PE Ratio3 Y	28.73x
PE Ratio5 Y	30.92x
PEG ratio	3.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	49.25%
EBITDA Margin	53.04%
FCF margin	18.43%
Gross margin	83.2%
Gross Profit	DKK 272.7B
Gross Profit Growth	6.28%
Gross Profit Growth Q	27.65%
Gross Profit Growth3 Y	19.81%
Gross Profit Growth5 Y	20.91%
Net Income	DKK 122B
Net Income Growth	16.58%
Net Income Growth Q	67.24%
Net Income Growth Quarters	1%
Net Income Growth Years	38%
Net Income Growth3 Y	25.89%
Net Income Growth5 Y	23.26%
Pretax Margin	47.49%
Profit Margin	37.2%
Profit Per Employee	DKK 1.8M
Profitable Years	41
ROA	19.25
Roa5y	21.35
ROCE	48.33
ROE	71.4
Roe5y	74.56
ROIC	40.42
Roic5y	68.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.67%
Cagr15y	12.94%
Cagr1y	-32.04%
Cagr20y	16.86%
Cagr3y	-16.91%
Cagr5y	6.84%
Div CAGR10	13.84%
Div CAGR3	23.58%
Div CAGR5	20.79%
EPS Growth	16.75
EPS Growth Q	67.08
EPS Growth Quarters	1
EPS Growth Years	31
EPS Growth3 Y	26.65
EPS Growth5 Y	24.4
FCF Growth	-23.77%
FCF Growth Q	12.96%
FCF Growth3 Y	-4.69%
FCF Growth5 Y	4.87%
OCF Growth	-9.84%
OCF Growth Q	-2.61%
OCF Growth10 Y	11.02%
OCF Growth3 Y	11.65%
OCF Growth5 Y	17.37%
Revenue Growth	8.13x
Revenue Growth Q	23.99x
Revenue Growth Quarters	1x
Revenue Growth Years	8x
Revenue Growth3 Y	20.3x
Revenue Growth5 Y	20.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	DKK 0.63
Assets	DKK 559.2B
Cash	DKK 21.6B
Current Assets	DKK 177.3B
Current Liabilities	DKK 225.2B
Debt	DKK 146.4B
Debt EBITDA	DKK 0.83
Debt Equity	DKK 0.72
Debt FCF	DKK 2.42
Equity	DKK 203.1B
Interest Coverage	38.38
Liabilities	DKK 356.2B
Long Term Assets	DKK 381.9B
Long Term Liabilities	DKK 131B
Net Cash	DKK -124.8B
Net Cash By Market Cap	DKK -9.69
Net Debt EBITDA	DKK 0.72
Net Debt Equity	DKK 0.61
Net Debt FCF	DKK 2.06
Tangible Book Value	DKK 73.2B
Tangible Book Value Per Share	DKK 16.47
WACC	5.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.79
Inventory Turnover	1.17
Net Working Capital	DKK -42.3B
Quick ratio	0.54
Working Capital	DKK -47.8B
Working Capital Turnover	DKK -5.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.2%
Dividend Growth	2.63%
Dividend Growth Years	8%
Dividend per share	DKK 11.7
Dividend Years	38
Dividend Yield	4.03%
Ex Div Date	2026-03-27
Last Dividend	DKK 7.95
Payout Frequency	Semi-Annual
Payout Ratio	42.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	109.31%
1Y total return	-32.02%
200-day SMA	318.3
3Y total return	-42.65%
50-day SMA	250.2
50-day SMA vs 200-day SMA	50under200
5Y total return	39.22%
All Time High	1,033.2
All Time High Change	-71.9%
All Time High Date	2024-06-26
All Time Low	2.48
All Time Low Change	11,629.29%
All Time Low Date	1992-09-02
ATR	10.37
Beta	0.35
Beta1y	1.21
Beta2y	1.07
Ch YTD	-10.75
High	294
High52	533.4
High52 Date	2025-06-13
High52ch	-45.58%
Low	287
Low52	224.3
Low52 Date	2026-03-02
Low52ch	29.45%
Ma50ch	16.02%
Price vs 200-day SMA	-8.79%
RSI	67.19
RSI Monthly	36.37
RSI Weekly	47.16
Sharpe ratio	-0.55x
Sortino ratio	-0.59
Total Return	4.23%
Tr YTD	-7.69
Tr15y	520.26%
Tr1m	23.48%
Tr1w	4.42%
Tr3m	1.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	DKK 161.4B
Operating Income Growth	10.7
Operating Income Growth Q	53.69
Operating Income Growth3 Y	25.63
Operating Income Growth5 Y	24.88
Operating margin	49.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,179,265,266%
Net Borrowing	24,157,000,000
Shares Insiders	0.02%
Shares Institutions	28.04%
Shares Out	4,432,851,022
Shares Qo Q	-0.02%
Shares Yo Y	-0.2%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	DKK 59B
Average Volume	5,930,939.3x
Bv Per Share	45.71
CAPEX	DKK -58B
Ch10y	66.12
Ch15y	351.1
Ch1m	23.48
Ch1w	4.42
Ch1y	-35.03
Ch20y	1,410
Ch3m	-1.76
Ch3y	-46.93
Ch5y	25.24
Ch6m	-0.31
Change	-1.76%
Change From Open	-1.16
Close	295.5
Days Gap	-0.61
Depreciation Amortization	12,431,000,000
Dollar Volume	1,339,536,225.1
Earnings Date	2026-05-06
EBIT	DKK 161.4B
EBITDA	DKK 173.9B
EPS	DKK 27.41
F Score	4
FCF	DKK 60.4B
FCF EV Yield	4.28x
FCF Per Share	DKK 13.63
Financing CF	-50,459,000,000
Fiscal Year End	December
Founded	1,923
Goodwill	19,877,000,000
Graham Number	168.39494
Graham Upside	-41.99
Income Tax	DKK 33.7B
Investing CF	-84,891,000,000
Is Primary Listing	1
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2023-09-13
Last Split Type	Forward
Lynch Fair Value	DKK 640
Lynch Upside	120.4
Ma150	306.2
Ma150ch	-5.18%
Ma20	264.8
Ma20ch	9.62%
Net CF	-17,811,000,000
Next Earnings Date	2026-08-05
Open	293.7
P FCF Ratio	21.3
P OCF Ratio	10.86
Payment Date	2026-03-31
Position In Range	47.14
Ppne	219,974,000,000
Price Date	2026-05-08
Price EBITDA	DKK 7.4
Ptbv Ratio	17.59
Relative Volume	0.78x
Revenue	327,800,000,000x
SBC By Revenue	0.44x
Share Based Comp	1,435,000,000
Tax By Revenue	10.29x
Tax Rate	21.66%
Tr20y	2,157.31%
Tr6m	3.1%
Volume	4,614,317
Z Score	4.66

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

CPH/NOVO.B dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.0%

$11.7 annual per share

Payout ratio

+42.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+20.8%

8 consecutive years of growth

Total shareholder yield

+4.2%

Next ex-dividend date: 2026-03-27

Performance

CPH/NOVO.B stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CPH/NOVO.B?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.0%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

CPH/NOVO.B momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.2

Neutral momentum band

Price vs 200-day MA

-8.8%

50/200-day relationship not available

Beta (5Y)

0.35

Less volatile than the market

Sharpe ratio

-0.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CPH/NOVO.B

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cph/NOVO.B stock rating?

cph/NOVO.B is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cph/NOVO.B analysis?

The full report lives at /stocks/cph/NOVO.B/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cph/NOVO.B?

The latest report frames cph/NOVO.B around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cph/NOVO.B page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.